BSB-1001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BSB-1001, covering 2025-09-18 to 2025-09-18. Get the full timeline:
Most recent: Clinical Trial Update: BSB-1001 in Patients Undergoing HLA-Matched Allogenic Hematopoietic Stem Cell Transplant for AML, ALL or MDS [Phase 1, Phase 2]